APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucosylceramidase

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Glucosylceramidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025189 pages

Choose your research edition.

Industry ResearchGlucosylceramidase Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucosylceramidase Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Glucosylceramidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucosylceramidase Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucosylceramidase Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Glucosylceramidase market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Glucosylceramidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucosylceramidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucosylceramidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Glucosylceramidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucosylceramidase include Takeda, The International Biotechnology Center (IBC) Generium, Protalix BioTherapeutics, Inc., Pharming Group N.V., JCR Pharmaceuticals Co., Ltd., greenovation Biotech GmbH, Bioorganic Research and Services S.A. and Amicus Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glucosylceramidase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucosylceramidase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucosylceramidase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucosylceramidase market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucosylceramidase Segment by Company

Takeda

The International Biotechnology Center (IBC) Generium

Protalix BioTherapeutics, Inc.

Pharming Group N.V.

JCR Pharmaceuticals Co., Ltd.

greenovation Biotech GmbH

Bioorganic Research and Services S.A.

Amicus Therapeutics, Inc.

Glucosylceramidase Segment by Type

Pcgin

NCGC-607

LTI-291

AVRRD-02

Others

Glucosylceramidase Segment by Application

Genetic Disorders

Parkinson's Disease

Gaucher Disease

Others

Glucosylceramidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucosylceramidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucosylceramidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucosylceramidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucosylceramidase market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucosylceramidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Glucosylceramidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Glucosylceramidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Glucosylceramidase Industry Trends Table 2. Glucosylceramidase Industry Drivers Table 3. Glucosylceramidase Industry Opportunities and Challenges Table 4. Glucosylceramidase Industry Restraints Table 5. Global Glucosylceramidase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Glucosylceramidase Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Glucosylceramidase Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Glucosylceramidase Sales Market Share by Manufacturers Table 9. Global Glucosylceramidase Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Glucosylceramidase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Glucosylceramidase Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Glucosylceramidase Manufacturers, Product Type & Application Table 13. Global Glucosylceramidase Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucosylceramidase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pcgin Table 17. Major Manufacturers of NCGC-607 Table 18. Major Manufacturers of LTI-291 Table 19. Major Manufacturers of AVRRD-02 Table 20. Major Manufacturers of Others Table 21. Global Glucosylceramidase Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Glucosylceramidase Sales by Type (2021-2026) & (K Units) Table 23. Global Glucosylceramidase Sales by Type (2027-2032) & (K Units) Table 24. Global Glucosylceramidase Sales Market Share by Type (2021-2026) Table 25. Global Glucosylceramidase Sales Market Share by Type (2027-2032) Table 26. Global Glucosylceramidase Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Glucosylceramidase Revenue by Type (2021-2026) & (K Units) Table 28. Global Glucosylceramidase Revenue by Type (2027-2032) & (K Units) Table 29. Global Glucosylceramidase Revenue Market Share by Type (2021-2026) Table 30. Global Glucosylceramidase Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Genetic Disorders Table 32. Major Manufacturers of Parkinson's Disease Table 33. Major Manufacturers of Gaucher Disease Table 34. Major Manufacturers of Others Table 35. Global Glucosylceramidase Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Glucosylceramidase Sales by Application (2021-2026) & (K Units) Table 37. Global Glucosylceramidase Sales by Application (2027-2032) & (K Units) Table 38. Global Glucosylceramidase Sales Market Share by Application (2021-2026) Table 39. Global Glucosylceramidase Sales Market Share by Application (2027-2032) Table 40. Global Glucosylceramidase Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Glucosylceramidase Revenue by Application (2021-2026) & (K Units) Table 42. Global Glucosylceramidase Revenue by Application (2027-2032) & (K Units) Table 43. Global Glucosylceramidase Revenue Market Share by Application (2021-2026) Table 44. Global Glucosylceramidase Revenue Market Share by Application (2027-2032) Table 45. Global Glucosylceramidase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Glucosylceramidase Sales by Region (2021-2026) & (K Units) Table 47. Global Glucosylceramidase Sales Market Share by Region (2021-2026) Table 48. Global Glucosylceramidase Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Glucosylceramidase Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Glucosylceramidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Glucosylceramidase Sales by Country (2021-2026) & (K Units) Table 52. North America Glucosylceramidase Sales by Country (2027-2032) & (K Units) Table 53. Europe Glucosylceramidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Glucosylceramidase Sales by Country (2021-2026) & (K Units) Table 55. Europe Glucosylceramidase Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Glucosylceramidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Glucosylceramidase Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Glucosylceramidase Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Glucosylceramidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Glucosylceramidase Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Glucosylceramidase Sales by Country (2027-2032) & (K Units) Table 62. Global Glucosylceramidase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Glucosylceramidase Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Glucosylceramidase Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Glucosylceramidase Revenue Market Share by Region (2021-2026) Table 66. Global Glucosylceramidase Revenue Market Share by Region (2027-2032) Table 67. Takeda Company Information Table 68. Takeda Business Overview Table 69. Takeda Glucosylceramidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Takeda Glucosylceramidase Product Portfolio Table 71. Takeda Recent Development Table 72. The International Biotechnology Center (IBC) Generium Company Information Table 73. The International Biotechnology Center (IBC) Generium Business Overview Table 74. The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. The International Biotechnology Center (IBC) Generium Glucosylceramidase Product Portfolio Table 76. The International Biotechnology Center (IBC) Generium Recent Development Table 77. Protalix BioTherapeutics, Inc. Company Information Table 78. Protalix BioTherapeutics, Inc. Business Overview Table 79. Protalix BioTherapeutics, Inc. Glucosylceramidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Protalix BioTherapeutics, Inc. Glucosylceramidase Product Portfolio Table 81. Protalix BioTherapeutics, Inc. Recent Development Table 82. Pharming Group N.V. Company Information Table 83. Pharming Group N.V. Business Overview Table 84. Pharming Group N.V. Glucosylceramidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pharming Group N.V. Glucosylceramidase Product Portfolio Table 86. Pharming Group N.V. Recent Development Table 87. JCR Pharmaceuticals Co., Ltd. Company Information Table 88. JCR Pharmaceuticals Co., Ltd. Business Overview Table 89. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product Portfolio Table 91. JCR Pharmaceuticals Co., Ltd. Recent Development Table 92. greenovation Biotech GmbH Company Information Table 93. greenovation Biotech GmbH Business Overview Table 94. greenovation Biotech GmbH Glucosylceramidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. greenovation Biotech GmbH Glucosylceramidase Product Portfolio Table 96. greenovation Biotech GmbH Recent Development Table 97. Bioorganic Research and Services S.A. Company Information Table 98. Bioorganic Research and Services S.A. Business Overview Table 99. Bioorganic Research and Services S.A. Glucosylceramidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Bioorganic Research and Services S.A. Glucosylceramidase Product Portfolio Table 101. Bioorganic Research and Services S.A. Recent Development Table 102. Amicus Therapeutics, Inc. Company Information Table 103. Amicus Therapeutics, Inc. Business Overview Table 104. Amicus Therapeutics, Inc. Glucosylceramidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Amicus Therapeutics, Inc. Glucosylceramidase Product Portfolio Table 106. Amicus Therapeutics, Inc. Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Glucosylceramidase Distributors List Table 110. Glucosylceramidase Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Glucosylceramidase Product Image Figure 2. Global Glucosylceramidase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucosylceramidase Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucosylceramidase Sales (2021-2032) & (K Units) Figure 5. Global Glucosylceramidase Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Glucosylceramidase Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pcgin Image Figure 9. NCGC-607 Image Figure 10. LTI-291 Image Figure 11. AVRRD-02 Image Figure 12. Others Image Figure 13. Global Glucosylceramidase Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Glucosylceramidase Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Glucosylceramidase Sales Market Share by Type (2021-2032) Figure 16. Global Glucosylceramidase Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Glucosylceramidase Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Glucosylceramidase Revenue Market Share by Type (2021-2032) Figure 19. Genetic Disorders Image Figure 20. Parkinson's Disease Image Figure 21. Gaucher Disease Image Figure 22. Others Image Figure 23. Global Glucosylceramidase Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Glucosylceramidase Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Glucosylceramidase Sales Market Share by Application (2021-2032) Figure 26. Global Glucosylceramidase Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Glucosylceramidase Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Glucosylceramidase Revenue Market Share by Application (2021-2032) Figure 29. North America Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Glucosylceramidase Sales Market Share by Country (2021-2032) Figure 31. U.S. Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Glucosylceramidase Sales Market Share by Country (2021-2032) Figure 36. Germany Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Glucosylceramidase Sales Market Share by Country (2021-2032) Figure 43. China Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Glucosylceramidase Sales Market Share by Country (2021-2032) Figure 51. Brazil Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Glucosylceramidase Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Glucosylceramidase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Glucosylceramidase Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Glucosylceramidase Revenue (2021-2032) & (US$ Million) Figure 62. North America Glucosylceramidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Glucosylceramidase Revenue (2021-2032) & (US$ Million) Figure 64. Europe Glucosylceramidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Glucosylceramidase Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Glucosylceramidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Glucosylceramidase Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Glucosylceramidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Glucosylceramidase Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Glucosylceramidase Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Pcgin
  • NCGC-607
  • LTI-291
  • AVRRD-02
  • Others
Applications
  • Genetic Disorders
  • Parkinson's Disease
  • Gaucher Disease
  • Others
Companies covered
  • Takeda
  • The International Biotechnology Center (IBC) Generium
  • Protalix BioTherapeutics, Inc.
  • Pharming Group N.V.
  • JCR Pharmaceuticals Co., Ltd.
  • greenovation Biotech GmbH
  • Bioorganic Research and Services S.A.
  • Amicus Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Glucosylceramidase Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Glucosylceramidase Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Glucosylceramidase Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Glucosylceramidase Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Glucosylceramidase Market Dynamics
  1. 2.1 Glucosylceramidase Industry Trends
  2. 2.2 Glucosylceramidase Industry Drivers
  3. 2.3 Glucosylceramidase Industry Opportunities and Challenges
  4. 2.4 Glucosylceramidase Industry Restraints
3 Glucosylceramidase Market by Manufacturers
  1. 3.1 Global Glucosylceramidase Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Glucosylceramidase Sales by Manufacturers (2021-2026)
  3. 3.3 Global Glucosylceramidase Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Glucosylceramidase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucosylceramidase Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Glucosylceramidase Manufacturers, Product Type & Application
  7. 3.7 Global Glucosylceramidase Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucosylceramidase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucosylceramidase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucosylceramidase Tier 1, Tier 2, and Tier 3
4 Glucosylceramidase Market by Type
  1. 4.1 Glucosylceramidase Type Introduction
  2. 4.1.1 Pcgin
  3. 4.1.2 NCGC-607
  4. 4.1.3 LTI-291
  5. 4.1.4 AVRRD-02
  6. 4.1.5 Others
  7. 4.2 Global Glucosylceramidase Sales by Type
  8. 4.2.1 Global Glucosylceramidase Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Glucosylceramidase Sales by Type (2021-2032)
  10. 4.2.3 Global Glucosylceramidase Sales Market Share by Type (2021-2032)
  11. 4.3 Global Glucosylceramidase Revenue by Type
  12. 4.3.1 Global Glucosylceramidase Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Glucosylceramidase Revenue by Type (2021-2032)
  14. 4.3.3 Global Glucosylceramidase Revenue Market Share by Type (2021-2032)
5 Glucosylceramidase Market by Application
  1. 5.1 Glucosylceramidase Application Introduction
  2. 5.1.1 Genetic Disorders
  3. 5.1.2 Parkinson's Disease
  4. 5.1.3 Gaucher Disease
  5. 5.1.4 Others
  6. 5.2 Global Glucosylceramidase Sales by Application
  7. 5.2.1 Global Glucosylceramidase Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Glucosylceramidase Sales by Application (2021-2032)
  9. 5.2.3 Global Glucosylceramidase Sales Market Share by Application (2021-2032)
  10. 5.3 Global Glucosylceramidase Revenue by Application
  11. 5.3.1 Global Glucosylceramidase Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Glucosylceramidase Revenue by Application (2021-2032)
  13. 5.3.3 Global Glucosylceramidase Revenue Market Share by Application (2021-2032)
6 Global Glucosylceramidase Sales by Region
  1. 6.1 Global Glucosylceramidase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucosylceramidase Sales by Region (2021-2032)
  3. 6.2.1 Global Glucosylceramidase Sales by Region (2021-2026)
  4. 6.2.2 Global Glucosylceramidase Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Glucosylceramidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Glucosylceramidase Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Glucosylceramidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Glucosylceramidase Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Glucosylceramidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Glucosylceramidase Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Glucosylceramidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Glucosylceramidase Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Glucosylceramidase Revenue by Region
  1. 7.1 Global Glucosylceramidase Revenue by Region
  2. 7.1.1 Global Glucosylceramidase Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Glucosylceramidase Revenue by Region (2021-2026)
  4. 7.1.3 Global Glucosylceramidase Revenue by Region (2027-2032)
  5. 7.1.4 Global Glucosylceramidase Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Glucosylceramidase Revenue (2021-2032)
  8. 7.2.2 North America Glucosylceramidase Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Glucosylceramidase Revenue (2021-2032)
  11. 7.3.2 Europe Glucosylceramidase Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Glucosylceramidase Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Glucosylceramidase Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Glucosylceramidase Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Glucosylceramidase Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Glucosylceramidase Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Glucosylceramidase Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 The International Biotechnology Center (IBC) Generium
  8. 8.2.1 The International Biotechnology Center (IBC) Generium Company Information
  9. 8.2.2 The International Biotechnology Center (IBC) Generium Business Overview
  10. 8.2.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 The International Biotechnology Center (IBC) Generium Glucosylceramidase Product Portfolio
  12. 8.2.5 The International Biotechnology Center (IBC) Generium Recent Developments
  13. 8.3 Protalix BioTherapeutics, Inc.
  14. 8.3.1 Protalix BioTherapeutics, Inc. Company Information
  15. 8.3.2 Protalix BioTherapeutics, Inc. Business Overview
  16. 8.3.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Protalix BioTherapeutics, Inc. Glucosylceramidase Product Portfolio
  18. 8.3.5 Protalix BioTherapeutics, Inc. Recent Developments
  19. 8.4 Pharming Group N.V.
  20. 8.4.1 Pharming Group N.V. Company Information
  21. 8.4.2 Pharming Group N.V. Business Overview
  22. 8.4.3 Pharming Group N.V. Glucosylceramidase Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pharming Group N.V. Glucosylceramidase Product Portfolio
  24. 8.4.5 Pharming Group N.V. Recent Developments
  25. 8.5 JCR Pharmaceuticals Co., Ltd.
  26. 8.5.1 JCR Pharmaceuticals Co., Ltd. Company Information
  27. 8.5.2 JCR Pharmaceuticals Co., Ltd. Business Overview
  28. 8.5.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product Portfolio
  30. 8.5.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
  31. 8.6 greenovation Biotech GmbH
  32. 8.6.1 greenovation Biotech GmbH Company Information
  33. 8.6.2 greenovation Biotech GmbH Business Overview
  34. 8.6.3 greenovation Biotech GmbH Glucosylceramidase Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 greenovation Biotech GmbH Glucosylceramidase Product Portfolio
  36. 8.6.5 greenovation Biotech GmbH Recent Developments
  37. 8.7 Bioorganic Research and Services S.A.
  38. 8.7.1 Bioorganic Research and Services S.A. Company Information
  39. 8.7.2 Bioorganic Research and Services S.A. Business Overview
  40. 8.7.3 Bioorganic Research and Services S.A. Glucosylceramidase Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bioorganic Research and Services S.A. Glucosylceramidase Product Portfolio
  42. 8.7.5 Bioorganic Research and Services S.A. Recent Developments
  43. 8.8 Amicus Therapeutics, Inc.
  44. 8.8.1 Amicus Therapeutics, Inc. Company Information
  45. 8.8.2 Amicus Therapeutics, Inc. Business Overview
  46. 8.8.3 Amicus Therapeutics, Inc. Glucosylceramidase Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Amicus Therapeutics, Inc. Glucosylceramidase Product Portfolio
  48. 8.8.5 Amicus Therapeutics, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucosylceramidase Value Chain Analysis
  2. 9.1.1 Glucosylceramidase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucosylceramidase Production Mode & Process
  6. 9.2 Glucosylceramidase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucosylceramidase Distributors
  9. 9.2.3 Glucosylceramidase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst